BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Wright Therapy Products Closes $3 Million Financing Round


12/7/2012 6:58:25 AM

PITTSBURGH, Dec. 7, 2012 /PRNewswire/ -- Wright Therapy Products, Inc., a market leader in providing home-based solutions for patients suffering from lymphedema and venous insufficiency, announced today that they successfully closed a $3 million Series B financing round. The capital raise was primarily subscribed by high-net-worth angel investors through Eagle Ventures, based in Shadyside, PA.

"We are very excited to complete the B round," said Michael Hinson, President and CEO of Wright Therapy. "This funding will allow us to continue expanding our solution across the entire U.S. Additionally, it will allow us to complete exciting new product development projects that we believe will lead to a significant competitive advantage in the marketplace by providing a unique treatment method for patients suffering from these life-altering diseases."

Jim Liken, Chairman of Wright's Board of Directors commented, "As a whole, our investors are very aware of the changing healthcare landscape and the need to provide cost-effective means to care for the patient. I believe that is what attracted the B round investors to Wright Therapy. Our ComplyCare solution is a disease management program focused on providing the most effective and compliant treatment for the patient which leads to the best clinical outcome."

About Wright Therapy Products, Inc.
Wright Therapy Products, Inc., based in Oakdale, Pennsylvania is a Joint Commission accredited medical device company that manufactures and sells pneumatic compression devices targeted for the home-based treatment of lymphedema and chronic venous insufficiency. The devices have received 510(k) Clearance from the U.S. FDA to treat these diseases. Our disease management program, ComplyCare, is a comprehensive patient compliance program that helps to ensure the best clinical outcome for the patient while reducing the overall cost-of-care. Our founder invented the world's first sequential gradient pump to treat a family member suffering from lymphedema and we continue to lead through innovation with a goal of providing the best treatment solution for patients afflicted with lymphedema or chronic venous insufficiency.

SOURCE Wright Therapy Products, Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->